E-Newsletter - December 2022
Spotlight on Alliance Committees

introducing new alliance pathology committee chair

Michael A. Linden, MD, PhD, has been appointed Chair of the Alliance Pathology Committee, effective December 2022. Dr. Linden replaces Eric D. Hsi, MD, Chair and Professor of Pathology in the Department of Pathology at Wake Forest School of Medicine, and Pathology/Laboratory Medicine Enterprise Service Leader and Academic Chair at Wake Forest Baptist Health, Atrium Health. Dr. Hsi retired as Committee Chair after 10-plus years of distinguished service in November 2022.

Dr. Linden is the Director of Hematopathology and a Professor within the Department of Laboratory Medicine and Pathology at the University of Minnesota, Minneapolis, MN. An international expert in flow cytometry, Dr. Linden previously led programs through the College of American Pathologists to standardize the validation and reporting of flow cytometric minimal residual disease testing (MRD) for leukemia, lymphoma, and myeloma, as well as created new products to measure and compare flow cytometric analytical performance among labs. He has been a member of the Alliance Pathology Committee and Alliance Myeloma Committee since 2017. Dr. Linden research focuses on improving and creating new diagnostic approaches for patients with myeloma and other hematologic malignancies.


Read other articles in this month's e-newsletter